Impact of oxidative stress SNPs and dietary antioxidant quality score on prostate cancer

References

• Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan JM. 2011. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 107(1):126–134.
   PubMed Web of Science ®Google Scholar
• Adzhubei I, Jordan DM, Sunyaev SR. 2013. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. Chapter 7:Unit 7.20.
   PubMedGoogle Scholar
• Bagheri A, Nachvak SM, Rezaei M, Moravridzade M, Moradi M, Nelson M. 2018. Dietary patterns and risk of prostate cancer: a factor analysis study in a sample of Iranian men. Health Promot Perspect. 8(2):133–138.
   PubMed Web of Science ®Google Scholar
• Bidoli E, Talamini R, Zucchetto A, Bosetti C, Negri E, Lenardon O, Maso LD, Polesel J, Montella M, Franceschi S, et al. 2009. Dietary vitamins E and C and prostate cancer risk. Acta Oncol. 48(6):890–894.
   PubMed Web of Science ®Google Scholar
• Chae YK, Huang H-Y, Strickland P, Hoffman SC, Helzlsouer K. 2009. Genetic polymorphisms of estrogen receptors α and β and the risk of developing prostate cancer. PloS One. 4(8):e6523.
   PubMed Web of Science ®Google Scholar
• Chan JM, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee G-SM, Sun T, Peisch S, Tinianow AM, Rae JM, et al. 2016. Selenium-or vitamin E–related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT. Cancer Epidemiol Prevent Biomark. 25(7):1050–1058.
   PubMed Web of Science ®Google Scholar
• Conesa-Zamora P, Ruiz-Cosano J, Torres-Moreno D, Español I, Gutiérrez-Meca MD, Trujillo-Santos J, Pérez-Ceballos E, González-Conejero R, Corral J, Vicente V, et al. 2013. Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study. BMC Cancer. 13(1):228.
   PubMedGoogle Scholar
• Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, Coombes JS. 2012. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene. 501(2):89–103.
   PubMed Web of Science ®Google Scholar
• Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. 1999. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer. 80(3-4):591–597.
   PubMed Web of Science ®Google Scholar
• Duru R, Njoku O, Maduka I. 2014. Oxidative stress indicators in patients with prostate disorders in Enugu, South-East Nigeria. Biomed Res Int. 2014:1.
   Web of Science ®Google Scholar
• Etminan M, FitzGerald JM, Gleave M, Chambers K. 2005. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 16(9):1125–1131.
   PubMed Web of Science ®Google Scholar
• Fu C, Dong WQ, Wang A, Qiu G. 2014. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk. Tumour Biol. 35(8):8319–8328.
   PubMedGoogle Scholar
• Geybels MS, van den Brandt PA, Schouten LJ, van Schooten FJ, van Breda SG, Rayman MP, Green FR, Verhage BA. 2014. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. J Natl Cancer Inst. 106(3): dju003.
   PubMedGoogle Scholar
• Geybels MS, van den Brandt PA, van Schooten FJ, Verhage BA. 2015. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 24(1):178–186.
   PubMed Web of Science ®Google Scholar
• Hu J, Feng F, Zhu S, Sun L, Li G, Jiang N, Shang Z, Niu Y. 2015. Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis. Gene. 558(2):265–270.
   PubMed Web of Science ®Google Scholar
• Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, et al. 2012. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr. 96(1):111–122.
   PubMed Web of Science ®Google Scholar
• Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, et al. 2015. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 102(5):1142–1157.
   PubMed Web of Science ®Google Scholar
• Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U, et al. 2006. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 98(4):245–254.
   PubMed Web of Science ®Google Scholar
• Kruk J, Aboul-Enein HY. 2017. Reactive oxygen and nitrogen species in carcinogenesis: implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem. 17(11):904–919.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, et al. 2016. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44(D1):D862–868.
   PubMed Web of Science ®Google Scholar
• Liu K, Liu X, Wang M, Wang X, Kang H, Lin S, Yang P, Dai C, Xu P, Li S, et al. 2016. Two common functional catalase gene polymorphisms (rs1001179 and rs794316) and cancer susceptibility: evidence from 14,942 cancer cases and 43,285 controls. Oncotarget. 7(39):62954–62965.
   PubMedGoogle Scholar
• Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, et al. 2003. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst. 95(11):812–818.
   PubMed Web of Science ®Google Scholar
• Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, et al. 2015. GermLine variation in superoxide dismutase-2 (SOD2) and survival outcomes after radiation therapy for prostate cancer: results of a test and validation set analysis. Clin Genitourin Cancer. 13(4):370–377.
   PubMed Web of Science ®Google Scholar
• McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S. 2005. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer. 53(1):33–41.
   PubMed Web of Science ®Google Scholar
• Mondul AM, Watters JL, Männistö S, Weinstein SJ, Snyder K, Virtamo J, Albanes D. 2011. Serum retinol and risk of prostate cancer. Am J Epidemiol. 173(7):813–821.
   PubMed Web of Science ®Google Scholar
• Moreiras O, Carbajal Á, Cabrera L, Cuadrado C. 2003. Food composition table. Spain: Pirámide.
   Google Scholar
• Peehl DM, Feldman D. 2003. The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer. 10(2):131–140.
   PubMed Web of Science ®Google Scholar
• Rivas A, Romero A, Mariscal-Arcas M, Monteagudo C, López G, Lorenzo ML, Ocaña-Peinado FM, Olea-Serrano F. 2012. Association between dietary antioxidant quality score (DAQs) and bone mineral density in Spanish women. Nutr Hosp. 27(6):1886–1893.
   PubMed Web of Science ®Google Scholar
• Schuurman AG, Goldbohm RA, Brants HA, van den Brandt PA. 2002. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control. 13(6):573–582.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Cooper DN, Schuelke M, Seelow D. 2014. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 11(4):361–362.
   PubMed Web of Science ®Google Scholar
• Shiota M, Fujimoto N, Itsumi M, Takeuchi A, Inokuchi J, Tatsugami K, Yokomizo A, Kajioka S, Uchiumi T, Eto M. 2017. Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress. Ann Oncol. 28(3):569–575.
   PubMed Web of Science ®Google Scholar
• Solé X, Guinó E, Valls J, Iniesta R, Moreno V. 2006. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 22(15):1928–1929.
   PubMed Web of Science ®Google Scholar
• The UniProt Consortium. 2017. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45(D1):D158–D169.
   PubMed Web of Science ®Google Scholar
• Traber M. 1999. Vitamin E. In Shils ME, Olson JA, Shike M, Ross AC eds. Modern nutrition in health and disease. Baltimore, MD: Williams & Wilkins.
   Google Scholar
• Urquiza-Salvat N, Pascual-Geler M, Lopez-Guarnido O, Rodrigo L, Martinez-Burgos A, Cozar JM, Ocaña-Peinado FM, Álvarez-Cubero MJ, Rivas A. 2019. Adherence to Mediterranean diet and risk of prostate cancer. Aging Male. 22(2):102–108.
   PubMed Web of Science ®Google Scholar
• Vance TM, Azabdaftari G, Pop EA, Lee SG, Su LJ, Fontham ET, Bensen JT, Steck SE, Arab L, Mohler JL, et al. 2016. Intake of dietary antioxidants is inversely associated with biomarkers of oxidative stress among men with prostate cancer. Br J Nutr. 115(1):68–74.
   PubMed Web of Science ®Google Scholar
• Vance TM, Wang Y, Su LJ, Fontham ET, Steck SE, Arab L, Bensen JT, Mohler JL, Chen MH, Chun OK. 2016. Dietary total antioxidant capacity is inversely associated with prostate cancer aggressiveness in a population-based study. Nutr Cancer. 68(2):214–224.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Q, Yuan S, Xie W, Liu Y, Xiang Y, Wu N, Wu L, Ma X, Cai T, et al. 2017. Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep. 7(1):8371.
   PubMedGoogle Scholar
• Willis MS, Wians FH. 2003. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta. 330(1-2):57–83.
   PubMed Web of Science ®Google Scholar
• Young B, Purcell C, Kuang YQ, Charette N, Dupré DJ. 2015. Superoxide dismutase 1 regulation of CXCR4-mediated signaling in prostate cancer cells is dependent on cellular oxidative state. Cell Physiol Biochem. 37(6):2071–2084.
   PubMedGoogle Scholar
• Zhang M, Xiong H, Fang L, Lu W, Wu X, Huang ZS, Wang YQ, Cai ZM, Wu S. 2015. Paraoxonase 1 (PON1) Q192R Gene polymorphism and cancer risk: a meta-analysis based on 30 publications. Asian Pac J Cancer Prev. 16(10):4457–4463.
   PubMedGoogle Scholar